HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel symmetric bis-benzimidazoles: Synthesis, DNA/RNA binding and antitrypanosomal activity.

Abstract
The novel benzimidazol-2-yl-fur-5-yl-(1,2,3)-triazolyl dimeric series with aliphatic and aromatic central linkers was successfully prepared with the aim of assessing binding affinity to DNA/RNA and antitrypanosomal activity. UV-Visible spectroscopy, thermal denaturation showed interaction of heterocyclic bis-amidines with ctDNA. Circular dichroism studies indicated uniform orientation of heterocyclic bis-amidines along the chiral double helix axis, revealing minor groove binding as the dominant binding mode. The amidino fragment and 1,4-bis(oxymethylene)phenyl spacer were the main determinants of activity against Trypanosoma brucei. The bis-benzimidazole imidazoline 15c, which had antitrypanosomal potency in the submicromolar range and DNA interacting properties, emerged as a candidate for further structural optimization to obtain more effective agents to combat trypanosome infections.
AuthorsA Bistrović Popov, I Stolić, L Krstulović, M C Taylor, J M Kelly, S Tomić, L Tumir, M Bajić, S Raić-Malić
JournalEuropean journal of medicinal chemistry (Eur J Med Chem) Vol. 173 Pg. 63-75 (Jul 01 2019) ISSN: 1768-3254 [Electronic] France
PMID30986572 (Publication Type: Journal Article)
CopyrightCopyright © 2019 Elsevier Masson SAS. All rights reserved.
Chemical References
  • Benzimidazoles
  • Trypanocidal Agents
  • bis-benzimidazole
Topics
  • Benzimidazoles (chemical synthesis, chemistry, pharmacology)
  • Binding Sites (drug effects)
  • Dose-Response Relationship, Drug
  • Molecular Structure
  • Parasitic Sensitivity Tests
  • Structure-Activity Relationship
  • Trypanocidal Agents (chemical synthesis, chemistry, pharmacology)
  • Trypanosoma brucei brucei (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: